Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial
Titel:
Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial
Auteur:
Langdahl, Bente L Libanati, Cesar Crittenden, Daria B Bolognese, Michael A Brown, Jacques P Daizadeh, Nadia S Dokoupilova, Eva Engelke, Klaus Finkelstein, Joel S Genant, Harry K Goemaere, Stefan Hyldstrup, Lars Jodar-Gimeno, Esteban Keaveny, Tony M Kendler, David Lakatos, Peter Maddox, Judy Malouf, Jorge Massari, Fabio E Molina, Jose Fernando Ulla, Maria Rosa Grauer, Andreas